Validation of the Omron M6 (HEM-7001-E) upper-arm blood pressure measuring device according to the International Protocol in adults and obese adults
- PMID: 17625394
- DOI: 10.1097/MBP.0b013e3280f813d0
Validation of the Omron M6 (HEM-7001-E) upper-arm blood pressure measuring device according to the International Protocol in adults and obese adults
Abstract
Background: Electronic blood pressure (BP) measurement devices are the preferred choice of patients owing to their user-friendly nature; however, there is a requirement to investigate the accuracy and reliability of these devices. The objective of this study is to evaluate the accuracy of the Omron M6 upper-arm BP device against the mercury sphygmomanometer in adults and obese adults according to the International Protocol criteria.
Methods: One hundred and twenty-one patients, older than 30 years of age, were studied and classified on the basis of the range of the International Protocol. BP measurements at the upper arm with the Omron M6 were compared with the results obtained by two trained observers using a mercury sphygmomanometer. Nine sequential BP measurements were taken. A total of 33 participants were selected for each validation study. During the validation study, 99 measurements were performed on 33 participants for comparison. The first phase was performed on 15 participants, and if the device passed this phase, 18 more participants were selected. Having a two-fold purpose, this study was conducted on both adult and obese adult patients.
Results: Mean discrepancies and standard deviations of the monitor-mercury sphygmomanometer were 1.1+/-4.0 mmHg for systolic BP (SBP) and -0.5+/-3.5 mmHg for diastolic BP (DBP) in the adult group. The device passed phase 1 in 15 participants. In phase 2.1, out of a total of 99 comparisons, 88, 96, and 97 for SBP, and 88, 98, and 99 for DBP were <5, <10, and <15 mmHg, respectively. Mean discrepancies and standard deviations of the monitor-mercury sphygmomanometer were 1.7+/-4.8 mmHg for SBP and -0.8+/-4.3 mmHg for DBP in the obese adult group. The device passed phase 1 in 15 participants. In phase 2.1, out of a total of 99 comparisons, 82, 90, and 97 for SBP, and 80, 97, and 99 for DBP were <5, <10, and <15 mmHg, respectively. It was found that the Omron M6 automatic monitor, which measures BP at the upper arm, produced results in accordance with the criteria of phases 2.1 and 2.2 in both SBP and DBP, when applied to adults and to obese adults.
Conclusion: It was concluded that the Omron M6 device, which measures BP at the upper arm, was deemed to be in accordance with the International Protocol criteria and can be recommended for use by adults and obese adults.
Similar articles
-
Validation of the Omron M6 (HEM-7001-E) upper arm blood pressure measuring device according to the International Protocol in elderly patients.Blood Press Monit. 2008 Apr;13(2):117-22. doi: 10.1097/MBP.0b013e3282f3fb50. Blood Press Monit. 2008. PMID: 18347447
-
Validation of the Omron 637IT wrist blood pressure measuring device with a position sensor according to the International Protocol in adults and obese adults.Blood Press Monit. 2006 Apr;11(2):79-85. doi: 10.1097/01.mbp.0000200483.49540.dc. Blood Press Monit. 2006. PMID: 16534409
-
Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT).Blood Press Monit. 2006 Jun;11(3):165-71. doi: 10.1097/01.mbp.0000209078.17246.34. Blood Press Monit. 2006. PMID: 16702826
-
Demise of the mercury sphygmomanometer and the dawning of a new era in blood pressure measurement.Blood Press Monit. 2003 Feb;8(1):19-21. doi: 10.1097/01.mbp.0000057012.67622.de. Blood Press Monit. 2003. PMID: 12604931 Review.
-
Can an automatic oscillometric device replace a mercury sphygmomanometer on blood pressure measurement? a systematic review and meta-analysis.Blood Press Monit. 2019 Dec;24(6):265-276. doi: 10.1097/MBP.0000000000000412. Blood Press Monit. 2019. PMID: 31658107
Cited by
-
Infant-feeding patterns and cardiovascular risk factors in young adulthood: data from five cohorts in low- and middle-income countries.Int J Epidemiol. 2011 Feb;40(1):47-62. doi: 10.1093/ije/dyq155. Epub 2010 Sep 17. Int J Epidemiol. 2011. PMID: 20852257 Free PMC article.
-
Agreement between community pharmacy and ambulatory and home blood pressure measurement methods to assess the effectiveness of antihypertensive treatment: the MEPAFAR study.J Clin Hypertens (Greenwich). 2012 Apr;14(4):236-44. doi: 10.1111/j.1751-7176.2012.00598.x. Epub 2012 Mar 5. J Clin Hypertens (Greenwich). 2012. PMID: 22458745 Free PMC article.
-
Acceptability and Adherence to Home, Kiosk, and Clinic Blood Pressure Measurement Compared to 24-H Ambulatory Monitoring.J Gen Intern Med. 2023 Jun;38(8):1854-1861. doi: 10.1007/s11606-023-08036-3. Epub 2023 Jan 17. J Gen Intern Med. 2023. PMID: 36650328 Free PMC article. Clinical Trial.
-
Uganda Genome Resource Enables Insights into Population History and Genomic Discovery in Africa.Cell. 2019 Oct 31;179(4):984-1002.e36. doi: 10.1016/j.cell.2019.10.004. Cell. 2019. PMID: 31675503 Free PMC article.
-
Blood pressure checks and diagnosing hypertension (BP-CHECK): Design and methods of a randomized controlled diagnostic study comparing clinic, home, kiosk, and 24-hour ambulatory BP monitoring.Contemp Clin Trials. 2019 Apr;79:1-13. doi: 10.1016/j.cct.2019.01.003. Epub 2019 Jan 8. Contemp Clin Trials. 2019. PMID: 30634036 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical